Logo image of CIT

CIT Group Inc (CIT) Stock Fundamental Analysis

NYSE:CIT - New York Stock Exchange, Inc. - Common Stock

53.5  +2.16 (+4.21%)

After market: 53.82 +0.32 (+0.6%)

Fundamental Rating

2

CIT gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 395 industry peers in the Banks industry. CIT has a bad profitability rating. Also its financial health evaluation is rather negative. CIT has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year CIT was profitable.
CIT Yearly Net Income VS EBIT VS OCF VS FCFCIT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 0 1B -1B 2B

1.2 Ratios

Industry RankSector Rank
ROA 1.31%
ROE 11.58%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CIT Yearly ROA, ROE, ROICCIT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 0 5 -5 -10

1.3 Margins

CIT does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 28.46%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CIT Yearly Profit, Operating, Gross MarginsCIT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 0 20 -20 40

More info and screens

1

2. Health

2.1 Basic Checks

Compared to 1 year ago, CIT has more shares outstanding
Compared to 1 year ago, CIT has an improved debt to assets ratio.
CIT Yearly Shares OutstandingCIT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 50M 100M 150M 200M
CIT Yearly Total Debt VS Total AssetsCIT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 20B 40B 60B

2.2 Solvency

CIT has a Debt/Equity ratio of 0.69. This is a neutral value indicating CIT is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A
CIT Yearly LT Debt VS Equity VS FCFCIT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 0 5B 10B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

More info and screens

4

3. Growth

3.1 Past

CIT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 455.37%, which is quite impressive.
Looking at the last year, CIT shows a small growth in Revenue. The Revenue has grown by 6.45% in the last year.
Measured over the past years, CIT shows a small growth in Revenue. The Revenue has been growing by 5.14% on average per year.
EPS 1Y (TTM)455.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%104.76%
Revenue 1Y (TTM)6.45%
Revenue growth 3Y-0.98%
Revenue growth 5Y5.14%
Sales Q2Q%-6.18%

3.2 Future

Based on estimates for the next years, CIT will show a very strong growth in Earnings Per Share. The EPS will grow by 25.51% on average per year.
Based on estimates for the next years, CIT will show a small growth in Revenue. The Revenue will grow by 4.10% on average per year.
EPS Next Y359.06%
EPS Next 2Y86.6%
EPS Next 3Y53.57%
EPS Next 5Y25.51%
Revenue Next Year4.36%
Revenue Next 2Y0.45%
Revenue Next 3Y4.22%
Revenue Next 5Y4.1%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CIT Yearly Revenue VS EstimatesCIT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B
CIT Yearly EPS VS EstimatesCIT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

CIT is valuated reasonably with a Price/Earnings ratio of 8.51.
CIT is valuated cheaply when we compare the Price/Earnings ratio to 26.25, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 11.72 indicates a reasonable valuation of CIT.
The average S&P500 Price/Forward Earnings ratio is at 22.15. CIT is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 8.51
Fwd PE 11.72
CIT Price Earnings VS Forward Price EarningsCIT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CIT Per share dataCIT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CIT's earnings are expected to grow with 53.57% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.02
PEG (5Y)N/A
EPS Next 2Y86.6%
EPS Next 3Y53.57%

More info and screens

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.73%, CIT has a reasonable but not impressive dividend return.
CIT's Dividend Yield is comparable with the S&P500 average which is at 2.40.
Industry RankSector Rank
Dividend Yield 2.73%

5.2 History

The dividend of CIT is nicely growing with an annual growth rate of 31.91%!
CIT has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)31.91%
Div Incr YearsN/A
Div Non Decr YearsN/A
CIT Yearly Dividends per shareCIT Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 0.2 0.4 0.6 0.8 1

5.3 Sustainability

CIT pays out 23.91% of its income as dividend. This is a sustainable payout ratio.
The dividend of CIT is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP23.91%
EPS Next 2Y86.6%
EPS Next 3Y53.57%
CIT Yearly Income VS Free CF VS DividendCIT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 0 500M -500M 1B -1B -1.5B
CIT Dividend Payout.CIT Dividend Payout, showing the Payout Ratio.CIT Dividend Payout.PayoutRetained Earnings

More info and screens

CIT Group Inc

NYSE:CIT (1/3/2022, 8:04:00 PM)

After market: 53.82 +0.32 (+0.6%)

53.5

+2.16 (+4.21%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)N/A N/A
Earnings (Next)02-01 2022-02-01/bmo
Inst Owners0%
Inst Owner Change0%
Ins Owners2.6%
Ins Owner Change0%
Market Cap5.28B
Analysts49.09
Price Target53.65 (0.28%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.73%
Yearly Dividend1.4
Dividend Growth(5Y)31.91%
DP23.91%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 8.51
Fwd PE 11.72
P/S 2.1
P/FCF N/A
P/OCF N/A
P/B 0.85
P/tB N/A
EV/EBITDA N/A
EPS(TTM)6.29
EY11.76%
EPS(NY)4.56
Fwd EY8.53%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS25.47
BVpS62.62
TBVpSN/A
PEG (NY)0.02
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.31%
ROE 11.58%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 28.46%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)455.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%104.76%
EPS Next Y359.06%
EPS Next 2Y86.6%
EPS Next 3Y53.57%
EPS Next 5Y25.51%
Revenue 1Y (TTM)6.45%
Revenue growth 3Y-0.98%
Revenue growth 5Y5.14%
Sales Q2Q%-6.18%
Revenue Next Year4.36%
Revenue Next 2Y0.45%
Revenue Next 3Y4.22%
Revenue Next 5Y4.1%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A